GSK’s gonorrhoea drug hits major target in late-stage trial
![](https://4gi.tv/wp-content/uploads/2024/02/2702-ws-he-1024x576.jpg)
British drugmaker GSK said its oral drug to treat gonorrhoea has achieved a key goal of staying ahead of existing combination drugs in late-stage trials. GSK said the study showed that the efficacy and safety of gepotidacin was no worse than the combination treatment of the muscle-injectable antibiotic ceftriaxone and the antibiotic tablet azithromycin.
POPULAR POSTS
![](https://4gi.tv/wp-content/uploads/2024/07/2607-02.png)
‘The Kardashians’ renewed by Hulu for 20 more episodes
July 26, 2024
![](https://4gi.tv/wp-content/uploads/2024/07/2607-ws-env2.jpg)
Death toll from landslides in Ethiopia could rise to 500
July 26, 2024
![](https://4gi.tv/wp-content/uploads/2024/07/2607-ws-env1.jpg)
![](https://4gi.tv/wp-content/uploads/2024/07/2607-ws-env.jpg)
The Canadian wildfire has made its way to Jasper
July 26, 2024
LIVE STREAM